[Thoracoscopic right middle lobectomy and adjuvant chemotherapy for pulmonary mucosal associated lymphoid tissue (MALT) lymphoma; report of a case].
A 37 year-old man with preoperative diagnosis of pulmonary mucosal associated lymphoid tissue (MALT) lymphoma underwent right middle lobectomy thoracoscopically followed by adjuvant chemotherapy since 18 days after the operation. The patient is free from recurrence 6 months after the operation. Pulmonary MALT lymphoma is rare and its treatment is controversial. This patient underwent surgical treatment and adjuvant chemotherapy because the tumor is limited to right middle lobe. Thoracoscopic lobectomy is less invasive and it was possible to perform adjuvant chemotherapy soon after the operation.
Homma
Shusaku
S
Department of Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
Yamamoto
Kazumichi
K
Ueda
Mitsuhiro
M
Miyamoto
Yoshihiro
Y
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000628:therapy*; D008297:Male; D011013:Pneumonectomy / Q000379:methods*; D000069283:Rituximab; D013906:Thoracoscopy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab